Literature DB >> 10981118

Hypertension in patients with pheochromocytoma.

N N Hanna1, D E Kenady.   

Abstract

Adrenal-dependent hypertension syndromes are uncommon forms of hypertension. They include primary aldosteronism, pheochromocytoma, Cushing"s syndrome, and congenital adrenal hyperplasia. Pheochromocytomas are the cause of hypertension in 0.1% to 0.2% of hypertensive patients. Excess catecholamine release and other neural and humoral mechanisms contribute to the pathophysiology of hypertension. Patients with pheochromocytomas have a potentially curable cause of endocrine hypertension and, if undetected, pheochromocytomas confer a high risk for morbidity and mortality, especially during surgical procedures and pregnancy. All patients with incidental adrenal tumors, regardless of tumor size, should be biochemically screened for pheochromocytoma (especially before resection or needle biopsy) to avoid precipitation of a lethal hypertensive crisis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10981118     DOI: 10.1007/s11906-996-0027-6

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  50 in total

1.  The surgical physiology of hypertension.

Authors:  R H SMITHWICK
Journal:  Surg Clin North Am       Date:  1949-12       Impact factor: 2.741

Review 2.  The adrenal incidentaloma: guidelines for evaluation and recommendations for management.

Authors:  D J Graham; C R McHenry
Journal:  Surg Oncol Clin N Am       Date:  1998-10       Impact factor: 3.495

3.  Mechanisms of orthostatic hypotension and tachycardia in patients with pheochromocytoma.

Authors:  D H Streeten; G H Anderson
Journal:  Am J Hypertens       Date:  1996-08       Impact factor: 2.689

Review 4.  Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma.

Authors:  E L Bravo
Journal:  Endocr Rev       Date:  1994-06       Impact factor: 19.871

5.  Blood pressure regulation in pheochromocytoma.

Authors:  E L Bravo; R C Tarazi; F M Fouad; S C Textor; R W Gifford; D G Vidt
Journal:  Hypertension       Date:  1982 May-Jun       Impact factor: 10.190

Review 6.  Pheochromocytoma. Update on diagnosis, localization, and management.

Authors:  S S Werbel; K P Ober
Journal:  Med Clin North Am       Date:  1995-01       Impact factor: 5.456

7.  Haemodynamic heterogeneity and treatment with the calcium channel blocker nicardipine during phaeochromocytoma surgery.

Authors:  P Colson; F Ryckwaert; J Ribstein; C Mann; S Dareau
Journal:  Acta Anaesthesiol Scand       Date:  1998-10       Impact factor: 2.105

8.  Comparison of adrenal and extraadrenal pheochromocytomas.

Authors:  R F Pommier; J T Vetto; K Billingsly; E A Woltering; M F Brennan
Journal:  Surgery       Date:  1993-12       Impact factor: 3.982

9.  Haemodynamics in patients with phaeochromocytoma.

Authors:  J A Levenson; M E Safar; G M London; A C Simon
Journal:  Clin Sci (Lond)       Date:  1980-05       Impact factor: 6.124

10.  Adrenocorticotropic hormone-secreting pheochromocytomas: the exception to the rule.

Authors:  H Chen; J L Doppman; G P Chrousos; J A Norton; L K Nieman; R Udelsman
Journal:  Surgery       Date:  1995-12       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.